Source link : https://newshealth.biz/health-news/car-t-for-multiple-myeloma-how-to-choose-between-therapies/
(MedPage Today) — CAR T-cell therapy targeting B-cell maturation antigen (BCMA) has become a game changer for patients with relapsed or refractory multiple myeloma. In 2021, the FDA approved idecabtagene vicleucel (ide-cel, Abecma) for patients… Source link : https://www.medpagetoday.com/spotlight/asco-mm/116214 Author : Publish date : 2025-06-24 14:47:00 Copyright for syndicated content belongs to the linked Source.
The post CAR-T for Multiple Myeloma: How to Choose Between Therapies? first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-24 14:47:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8